Study to Evaluate Effectiveness of Aranesp®
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00117130|
Recruitment Status : Completed
First Posted : July 4, 2005
Last Update Posted : January 21, 2011
|Condition or disease||Intervention/treatment||Phase|
|Kidney Disease||Drug: Aranesp®||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Aranesp® Monthly Preference Study|
- Subject preference
- Subject productivity and subject selection of Aranesp® or Procrit® therapy in the parallel arm portion and at study conclusion.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00117130